Research Article

In Vitro Evaluation of Antimicrobial Efficacy of Extracts Obtained from Raw and Fermented Wild Macrofungus, Lenzites quercina

Table 4

Zones of inhibition of purified fractions against tested organisms at 2.0 mg/mL.

Indicator organismsRPERCLRMTFPE

S. aureus (ATCC 29213)18.0 ± 0.00.014.0 ± 0.00.0
E. coli (ATCC 35218)15.0 ± 0.00.011.1 ± 0.20.0
P. aeruginosa (ATCC 27853)0.011.0 ± 0.017.0 ± 0.00.0
S. flexneri (ATCC 12022)0.00.08.0 ± 0.00.0
S. enterica (ATCC 33458)6.3 ± 0.018.0 ± 0.00.00.0
B. subtilis (ATCC 6633)0.00.010.0 ± 0.06.0 ± 0.0
E. aerogenes (ATCC 13043)21.5 ± 0.020.00.08.0 ± 0.2
Shigella flexneri0.00.010.0 ± 0.00.0
S. typhi26.0 ± 0.00.018.0 ± 0.00.0
Pseudomonas aeruginosa0.00.016.2 ± 0.60.0
Bacillus cereus0.00.023.0 ± 0.011.0 ± 0.3
Enterococci faecalis0.00.020.0 ± 0.00.0
E. coli13.3 ± 0.40.00.00.0
MRSA-10.00.019.0 ± 0.00.0
MRSA-20.00.00.00.0
MRSA-30.00.00.00.0
MRSA-410.2 ± 0.20.00.09.1 ± 0.23
MRSA-50.00.015.1 ± 0.30.0
MRSA-60.00.013.2 ± 0.10.0
S. aureus22.0 ± 0.00.016.0 ± 0.00.0
Candida albicans13.1 ± 0.30.00.00.0
Aspergillus niger20.0 ± 0.00.00.00.0
Aspergillus flavus17.0 ± 0.00.00.00.0

Values are mean ± sd of replicates ().
RPE: pet-ether fraction, RCL: chloroform fractions, RMT: methanol fraction, FPE: pet-ether fraction (fermented L. quercina), and 0.0: no zone of inhibition at 2.0 mg/mL.